← Leaderboards
Benita Tamrazi
Children'S Hospital Of Los Angeles
$1,218,457
Attributed
$2,791,640
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $805.1K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,791,640 · 2
By mechanism
R01$2,359,774 · 1
R21$431,866 · 1
Top collaborators
- Deepak Nagrath4 shared
- Sriram Venneti4 shared
Most similar at Children'S Hospital Of Los Angeles
Same institution · by research overlap
- Mary Baron Nelson$395,644
Others in their field
Other Emerging Leaders on “In Vivo”
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,216,744
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
- John Damon Chodera · Sloan-Kettering Inst Can Research$43,427,103
- Tony Moody · Duke University$34,777,314
- Alan D. Palkowitz · Indiana University Indianapolis$18,925,366
Research focus
In VivoLinkMorbidity - Disease RateChildMolecularRadiationCritiquesClinical Trials DesignDemethylationCitric Acid CycleAdolescentBiologyCofactorCombatClinical TrialsDesignChildhood EpendymomaAdultAdjuvant TherapyCell LineBiologicalCell ProliferationCellsChip-Seq
Grant awards (6)
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas$596,380
R01 · FY2025 · CA
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas$567,330
R01 · FY2024 · CA
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas$585,078
R01 · FY2023 · CA
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas$610,986
R01 · FY2022 · CA
Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors$194,142
R21 · FY2022 · CA · contact PI
Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors$237,724
R21 · FY2021 · CA · contact PI